![]() |
Volumn 29, Issue 1-2, 1997, Pages 1065-1066
|
Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival
a,b
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
LYMPHOCYTE ANTIBODY;
ALLOGRAFT;
ANIMAL CELL;
ANIMAL MODEL;
CONFERENCE PAPER;
CONTROLLED STUDY;
GRAFT SURVIVAL;
GRAFT VERSUS HOST REACTION;
IMMUNOMODULATION;
INTESTINE TRANSPLANTATION;
INTRAPERITONEAL DRUG ADMINISTRATION;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
SPLEEN CELL;
THYMUS;
TREATMENT OUTCOME;
ANIMALS;
ANTIGENS, CD;
ANTIGENS, DIFFERENTIATION;
ANTILYMPHOCYTE SERUM;
GRAFT SURVIVAL;
GRAFT VS HOST DISEASE;
IMMUNOCONJUGATES;
IMMUNOSUPPRESSION;
INTESTINE, SMALL;
LYMPHOCYTE TRANSFUSION;
RATS;
RATS, INBRED BN;
RATS, INBRED LEW;
SPLEEN;
T-LYMPHOCYTES;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0030898237
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00399-5 Document Type: Conference Paper |
Times cited : (5)
|
References (6)
|